Drug-Eluting Stents in Multivessel Coronary Artery Disease: Cost Effectiveness and Clinical Outcomes
Multivessel coronary artery disease is more often treated either with coronary artery bypass surgery (CABG) or percutaneous coronary intervention (PCI) with stenting. The advent of drug-eluting stent (DES) has changed the revascularization strategy, and caused an increase in the use of DES in multiv...
Main Authors: | Kanaiya Panchal, Snehal Patel, Parloop Bhatt |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Advances in Pharmacological Sciences |
Online Access: | http://dx.doi.org/10.1155/2012/679013 |
Similar Items
-
A Combination of Drug-Eluting Stents and Bioresorbable Vascular Scaffolds in the Treatment of Multivessel Coronary Artery Disease
by: Ahmed Al-Mamary, et al.
Published: (2016-08-01) -
Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with second-generation drug-eluting stents for patients with multivessel and unprotected left main coronary artery disease
by: Kyriacos Papadopoulos, et al.
Published: (2017-01-01) -
One-Year clinical outcomes of drug-eluting stents versus bare-metal stents in large coronary arteries
by: Roopesh Singhal, et al.
Published: (2020-01-01) -
Second Generation Drug-Eluting Stent Implantation versus Coronary Artery Bypass Grafting in the Treatment of Young Patients with Left Main and/or Multivessel Coronary Disease
by: Xue Chen, et al.
Published: (2020-01-01) -
Understanding the Outcome of Randomized Trials with Drug-Eluting Stents and Coronary Artery Bypass Graft in Patients with Multivessel Disease: A Review of a 25-Year Journey
by: Alfredo E. Rodriguez, et al.
Published: (2016-12-01)